These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29644059)

  • 1. Mutations in
    Khandelwal P; Birla S; Bhatia D; Puraswani M; Saini H; Sinha A; Hari P; Sharma A; Bagga A
    Clin Kidney J; 2018 Apr; 11(2):198-203. PubMed ID: 29644059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Studies and an
    Piras R; Iatropoulos P; Bresin E; Todeschini M; Gastoldi S; Valoti E; Alberti M; Mele C; Galbusera M; Cuccarolo P; Benigni A; Remuzzi G; Noris M
    Front Med (Lausanne); 2020; 7():579418. PubMed ID: 33224962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
    Mohlin FC; Nilsson SC; Levart TK; Golubovic E; Rusai K; Müller-Sacherer T; Arbeiter K; Pállinger É; Szarvas N; Csuka D; Szilágyi Á; Villoutreix BO; Prohászka Z; Blom AM
    Mol Immunol; 2015 Jun; 65(2):367-76. PubMed ID: 25733390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel homozygous CD46 variant with C-isoform expression affects C3b inactivation in atypical hemolytic uremic syndrome.
    Schack VR; Herlin MK; Pedersen H; Jensen JMB; Faerch M; Bundgaard B; Jensen RK; Jensen UB; Christensen R; Andersen GR; Thiel S; Höllsberg P
    Eur J Immunol; 2022 Oct; 52(10):1610-1619. PubMed ID: 35987516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
    Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
    J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
    Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
    Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome.
    Bhatia D; Khandelwal P; Sinha A; Hari P; Cheong HI; Bagga A
    Pediatr Nephrol; 2015 Dec; 30(12):2215-20. PubMed ID: 26307634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
    J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound Haplotype Variants in
    Furmańczyk-Zawiska A; Kubiak-Dydo A; Użarowska-Gąska E; Kotlarek-Łysakowska M; Salata K; Kolanowska M; Świerniak M; Gaj P; Leszczyńska B; Daniel M; Jażdżewski K; Durlik M; Wójcicka A
    J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33920896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and functional analysis of two missense mutations in CD46 predispose to postpartum atypical hemolytic uremic syndrome.
    Wu H; Mao Z; Tan Y; Jiang Y; Yu J; Song L; Wu S; Sun M; Zhu L; Yu X; Zhang L; Yu F; Zhao MH
    Clin Chim Acta; 2020 Apr; 503():61-69. PubMed ID: 31945341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair.
    Couzi L; Contin-Bordes C; Marliot F; Sarrat A; Grimal P; Moreau JF; Merville P; Fremeaux-Bacchi V
    Am J Kidney Dis; 2008 Aug; 52(2):e5-9. PubMed ID: 18514989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).
    Watson R; Wearmouth E; McLoughlin AC; Jackson A; Ward S; Bertram P; Bennaceur K; Barker CE; Pappworth IY; Kavanagh D; Lea SM; Atkinson JP; Goodship TH; Marchbank KJ
    Mol Immunol; 2015 Feb; 63(2):287-96. PubMed ID: 25150608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
    Martínez-Barricarte R; Heurich M; López-Perrote A; Tortajada A; Pinto S; López-Trascasa M; Sánchez-Corral P; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
    Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.
    Fakhouri F; Fila M; Provôt F; Delmas Y; Barbet C; Châtelet V; Rafat C; Cailliez M; Hogan J; Servais A; Karras A; Makdassi R; Louillet F; Coindre JP; Rondeau E; Loirat C; Frémeaux-Bacchi V
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):50-59. PubMed ID: 27799617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.
    Pabst WL; Neuhaus TJ; Nef S; Bresin E; Zingg-Schenk A; Spartà G
    Pediatr Nephrol; 2013 Jul; 28(7):1141-4. PubMed ID: 23519521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P; Dickenmann M; Schifferli JA
    Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database.
    Puraswani M; Khandelwal P; Saini H; Saini S; Gurjar BS; Sinha A; Shende RP; Maiti TK; Singh AK; Kanga U; Ali U; Agarwal I; Anand K; Prasad N; Rajendran P; Sinha R; Vasudevan A; Saxena A; Agarwal S; Hari P; Sahu A; Rath S; Bagga A
    Front Immunol; 2019; 10():1282. PubMed ID: 31231391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.